Harmony Biosciences Holdings, Inc. today announced strong preliminary, unaudited net product revenue for Q4 and full year ...
Vir Biotechnology, Inc. today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving the combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback